Inside Eli Lilly Insider Sales: What Melissa’s Recent Move Signals for 2025‑26
Explore how Eli Lilly’s recent insider sales, led by EVP Seymour Melissa, signal routine portfolio moves amid rising GLP‑1 demand and a 37.73‑P/E valuation.
3 minutes to read